Skip to main content

Table 1 Global hemodynamics

From: Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock

Parameter

Group

BL = 0 hours

3 hours

6 hours

12 hours

18 hours

24 hours

CVP (mmHg)

Sham

7 ± 1

13 ± 2#

12 ± 1#

11 ± 1#

10 ± 1#

10 ± 1#

 

Control

6 ± 1

9 ± 1#

11 ± 1#

13 ± 1#

14 ± 1#†

15 ± 1#†

 

rhAPC

5 ± 1

10 ± 1#

11 ± 1#

11 ± 1#

13 ± 1#

13 ± 2#

MPAP (mmHg)

Sham

23 ± 1

26 ± 1

27 ± 1

26 ± 1

26 ± 1

27 ± 1#

 

Control

21 ± 1

26 ± 2#

31 ± 2#†

28 ± 1#

30 ± 1#

33 ± 1#†

 

rhAPC

20 ± 1

25 ± 1#

25 ± 1#*

27 ± 2#

30 ± 2#

28 ± 2#*

PAOP (mmHg)

Sham

11 ± 1

14 ± 1#

15 ± 1#

14 ± 1#

16 ± 1#

14 ± 1#

 

Control

10 ± 1

15 ± 1#

16 ± 1#

17 ± 1#

17 ± 1#

18 ± 1#†

 

rhAPC

11 ± 1

16 ± 1#

16 ± 1#

17 ± 1#

17 ± 1#

16 ± 1#*

LAP (mmHg)

Sham

7 ± 0

9 ± 1#

10 ± 1#

9 ± 1#

9 ± 1#

9 ± 1#

 

Control

7 ± 1

11 ± 1#

15 ± 2#†

15 ± 1#†

17 ± 1†

19 ± 1#†

 

rhAPC

9 ± 2

9 ± 1

11 ± 1*

13 ± 1#†

15 ± 1#†

14 ± 2#†*

CI (l/min/m2)

Sham

5.6 ± 0.1

5.3 ± 0.3

5.1 ± 0.1

4.8 ± 0.1

4.8 ± 0.1

4.6 ± 0.1

 

Control

5.3 ± 0.3

5.8 ± 0.5

6.2 ± 0.4#†

6.5 ± 0.3#†

6.9 ± 0.3#†

8.7 ± 0.4#†

 

rhAPC

5.0 ± 0.2

5.2 ± 0.4

5.5 ± 0.4

5.7 ± 0.3†*

6.1 ± 0.2#†*

6.2 ± 0.2#†*

SVRI (dyne s/cm5/m2)

Sham

1289 ± 87

1374 ± 133

1402 ± 103

1502 ± 64

1576 ± 79

1599 ± 96

 

Control

1419 ± 59

1224 ± 92

1128 ± 85#

740 ± 50#†

632 ± 52#†

502 ± 42#†

 

rhAPC

1464 ± 79

1364 ± 187

1334 ± 188

1111 ± 64#†*

968 ± 51#†*

934 ± 41#†*

PaO2:FiO2 ratio

Sham

506 ± 10

471 ± 11

490 ± 18

492 ± 17

498 ± 16

491 ± 19

 

Control

521 ± 19

202 ± 36#†

144 ± 26#†

72 ± 5#†

72 ± 7#†

74 ± 6#†

 

rhAPC

541 ± 10

245 ± 56#†

176 ± 39#†

151 ± 24#†*

134 ± 22#†*

118 ± 17#†

PaCO2 (mmHg)

Sham

32 ± 1

29 ± 1

26 ± 1#

25 ± 1#

23 ± 2#

24 ± 1#

 

Control

37 ± 2

29 ± 3#

27 ± 3#

28 ± 2#

29 ± 0#

29 ± 2#

 

rhAPC

36 ± 0

25 ± 3#

27 ± 2#

25 ± 2#

27 ± 2#

27 ± 4#

apH (-log10[H+])

Sham

7.469 ± 0.012

7.542 ± 0.027#

7.537 ± 0.014#

7.558 ± 0.019#

7.583 ± 0.015#

7.548 ± 0.026#

 

Control

7.449 ± 0.014

7.577 ± 0.031#

7.564 ± 0.025#

7.525 ± 0.012#

7.465 ± 0.031†

7.437 ± 0.027†

 

rhAPC

7.470 ± 0.010

7.622 ± 0.026#†

7.590 ± 0.018#

7.556 ± 0.016#

7.509 ± 0.024†

7.480 ± 0.043†

DO2I (ml/min/m2)

Sham

607 ± 33

651 ± 49

648 ± 57

567 ± 48

565 ± 38

551 ± 41

 

Control

580 ± 70

663 ± 58

719 ± 62#

709 ± 27#

726 ± 67#

984 ± 82#†

 

rhAPC

624 ± 32

638 ± 43

690 ± 51

644 ± 56

650 ± 40

666 ± 37#*

VO2I (ml/min/m2)

Sham

209 ± 21

198 ± 26

183 ± 21

170 ± 21

195 ± 31

165 ± 23

 

Control

242 ± 24

220 ± 30

231 ± 30

215 ± 35

178 ± 29

274 ± 41

 

rhAPC

197 ± 16

244 ± 24

227 ± 24

193 ± 31

186 ± 25

253 ± 39

Temperature (°C)

Sham

39.0 ± 0.1

39.5 ± 0.1

39.5 ± 0.1

39.2 ± 0.2

39.1 ± 0.1

39.2 ± 0.1

 

Control

39.1 ± 0.1

40.2 ± 0.2#†

40.5 ± 0.2#†

40.4 ± 0.2#†

40.1 ± 0.2#†

40.1 ± 0.3#†

 

rhAPC

39.3 ± 0.1

40.0 ± 0.2#†

40.5 ± 0.2#†

40.5 ± 0.1#†

40.4 ± 0.2#†

40.4 ± 0.1#†

Hematocrit (%)

Sham

25.2 ± 0.8

26.2 ± 1.2

26.0 ± 1.6

25.0 ± 1.3

24.7 ± 1.0

24.7 ± 1.0

 

Control

25.3 ± 1.0

27.5 ± 0.9#

28.3 ± 0.8#

29.7 ± 0.9#†

28.8 ± 1.2#

28.9 ± 0.7#†

 

rhAPC

28.2 ± 0.9

27.7 ± 1.1

29.7 ± 1.3

28.3 ± 0.9†

28.3 ± 1.0

27.2 ± 0.7†

Plasma NOx (μM)

Sham

5.0 ± 0.6

5.4 ± 0.6

5.4 ± 0.8

5.0 ± 0.9

5.8 ± 0.7

6.0 ± 0.7

 

Control

5.2 ± 0.5

7.1 ± 0.8#

7.9 ± 0.8#†

9.0 ± 1.2#†

9.8 ± 1.1#†

10.5 ± 1.1#†

 

rhAPC

4.6 ± 0.6

7.8 ± 0.6#

9.4 ± 0.5#†

9.6 ± 1.1#†

9.5 ± 1.1#†

8.9 ± 0.8#†

Plasma Onc (mmHg)

Sham

21.9 ± 0.4

20.9 ± 0.7

20.2 ± 0.9

20.8 ± 0.6

22.1 ± 0.5

22.5 ± 0.7

 

Control

22.7 ± 0.9

19.5 ± 0.4#

16.2 ± 0.7#†

14.4 ± 0.7#†

12.5 ± 0.8#†

10.9 ± 1.0#†

 

rhAPC

24.3 ± 0.4

22.7 ± 0.3*

21.0 ± 0.3#*

18.3 ± 0.7#†*

15.9 ± 1.3#†*

14.7 ± 1.5#†*

  1. CVP, central venous pressure; MPAP, mean pulmonary artery pressure; PAOP, pulmonary artery occlusion pressure; LAP, left atrial pressure; CI, cardiac index; SVRI, systemic vascular resistance index; PaO2:FiO2 ratio, Horovitz quotient; PaCO2, arterial carbon dioxide partial pressure; apH, arterial pH; DO2I, oxygen delivery index; VO2I, oxygen consumption index; NOx, nitrate-to-nitrite formation; Onc, oncotic pressure; rhAPC, recombinant human activated protein C. P ≤0.05: #versus baseline, †versus sham, *versus control.